The Business Research Company’s Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact And Recovery To 2030
LONDON, GREATER LONDON, UK, August 6, 2021 /EINPresswire.com/ — Hormonal replacement therapy drugs such as Estrogen, Progestin, and others are used to treat medical conditions caused due to menopausal conditions. According to a report by The Indian Menopause Society, New Delhi, in India there are 65 million women over the menopausal age affected with menopausal symptoms. According to European Menopause and Andropause Society (EMAS) report, women aged over 60 are expected to reach over 1 billion by 2050. In South Korea, the female population is expected to exceed the male population by 2060, out of which 59.6% of the female population is expected to suffer from postmenopausal symptoms. Thus, the growing population suffering from menopausal symptoms and the aging population drive the market for hormonal replacement therapy drugs market.
The global drug for hormonal replacement therapy market size is expected to grow from $14.76 billion in 2020 to $14.88 billion in 2021 at a compound annual growth rate (CAGR) of 0.8%. The slow growth is mainly due to deferring treatments that led to a fall in the demand for drugs. The hormone replacement therapy drugs market size expected to reach $16.77 billion in 2025 at a CAGR of 3%.
Read More On The Global Drugs For Hormonal Replacement Therapy Market Report:
The drug for hormonal replacement therapy market consists of sales of drugs for hormonal replacement therapy and related services. The drugs for hormonal replacement therapy are used to treat patients with growth hormone deficiency caused due to conditions such as dwarfism or menopause (a condition that describes changes a woman goes through when her menstruating cycle stops). The drugs for hormonal replacement therapy help to replace low-level hormones from the body, maintain growth hormone deficiency and prevent women from vaginal dryness, mood swings, weakening of bones, and others.
Major players with HRT drugs market shares are Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, and Eli Lilly and Company.
TBRC’s drugs for hormonal replacement therapy market report is segmented by therapy type into estrogen replacement therapy, human growth hormone (HGH) replacement therapy, thyroid replacement therapy, testosterone replacement therapy; by distribution channel into hospital pharmacies, retail pharmacies, online pharmacies; by application into hypothyroidism, male hypogonadism, growth hormone deficiency, menopause, others; by route of administration into oral, parental, others.
Drugs For Hormonal Replacement Therapy Global Market Report 2021: COVID-19 Impact And Recovery To 2030 is one of a series of new reports from The Business Research Company that provides drugs for hormonal replacement therapy market overview, forecast drugs for hormonal replacement therapy market size and growth for the whole market, drugs for hormonal replacement therapy market segments, and geographies, drugs for hormonal replacement therapy market trends, drugs for hormonal replacement therapy market drivers, restraints, leading competitors’ revenues, profiles, and market shares.
Request For A Sample Of The Global Drugs For Hormonal Replacement Therapy Market Report:
Here Is A List Of Similar Reports By The Business Research Company:
Biosimilar Growth Hormones Global Market Report 2021: COVID-19 Growth And Change To 2030
Anti-Thyroid Drugs Global Market Report 2021: COVID-19 Impact And Recovery To 2030
Parathyroid Hormone Global Market Report 2021: COVID-19 Growth And Change To 2030
Interested to know more about The Business Research Company?
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293